Home › NDC Lookup › RxCUI directory › RxCUI 1666328

Nonacog alfa 1 UNT Injection [Ixinity] — RxCUI 1666328

RxNorm drug concept · Semantic branded drug
RxCUI 1666328 Semantic branded drug · SBD ● Current RxNorm concept 6 FDA products 4 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1666328
Official nameNonacog alfa 1 UNT Injection [Ixinity]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asIxinity (coagulation factor IX (recombinant human)) 1 UNT Injection; IXINITY 1 UNT Injection
FDA products mapped6
Package NDCs mapped4
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

🕸️ Concept Web — How Nonacog alfa 1 UNT Injection [Ixinity] Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Nonacog alfa 1 UNT Injection [Ixinity] RxCUI 1666328

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Factor IX 4249
    • Nonacog alfa 1300488
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Ixinity 1666324
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Factor IX Injection 1666302
    • Nonacog alfa Injection 2646725
    • Factor IX Injectable Product 1158487
    • Nonacog alfa Injectable Product 2660026
    • Factor IX Injection [Ixinity] 1666326
    • Nonacog alfa Injection [Ixinity] 2656187
    • Ixinity Injectable Product 1666327
    • Injection 1649574
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 14 of 15 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Nonacog alfa 1 UNT Injection SCD · 1666311
  • Nonacog alfa 1 UNT SCDC · 1666310
  • Factor IX Injection SCDF · 1666302
  • Nonacog alfa Injection SCDFP · 2646725
  • Factor IX Injectable Product SCDG · 1158487
  • Nonacog alfa Injectable Product SCDGP · 2660026

Brand-Name Concepts

  • Nonacog alfa 1 UNT [Ixinity] SBDC · 1666325
  • Factor IX Injection [Ixinity] SBDF · 1666326
  • Nonacog alfa Injection [Ixinity] SBDFP · 2656187
  • Ixinity Injectable Product SBDG · 1666327
  • Ixinity BN · 1666324

📦 FDA Products & Package NDCs

6 products · 4 package NDCs
4 package NDCs map to RxCUI 1666328 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
59137-0282-05 1 KIT in 1 CARTON (59137-282-05) * 5 mL in 1 VIAL (59137-2... Ixinity Medexus Pharma, Inc. 2021-07-01
59137-0283-05 1 KIT in 1 CARTON (59137-283-05) * 5 mL in 1 VIAL (59137-2... Ixinity Medexus Pharma, Inc. 2021-07-01
59137-0284-05 1 KIT in 1 CARTON (59137-284-05) * 5 mL in 1 VIAL (59137-2... Ixinity Medexus Pharma, Inc. 2021-07-01
59137-0289-05 1 KIT in 1 CARTON (59137-289-05) * 5 mL in 1 VIAL (59137-2... Ixinity Medexus Pharma, Inc. 2021-07-01
Observed labelers: Medexus Pharma, Inc. (4) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🧾 Billing Codes (HCPCS)

Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.
CodeDescriptorMapped packagesSources
J7213 Inj, ixinity, 1 i.u. 4 CMS
⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.